Literature DB >> 18265660

Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy.

Atsushi Nanashima1, Yorihisa Sumida, Takafumi Abo, Toshiya Nagasaki, Hiroaki Takeshita, Hidetoshi Fukuoka, Terumitsu Sawai, Kenji Tanaka, Toru Yasutake, Takeshi Nagayasu.   

Abstract

BACKGROUND/AIMS: The present study was designed to provide a systematic analysis of prognosis of patients who underwent hepatic resection for intrahepatic cholangiocarcinoma (ICC).
METHODOLOGY: Subjects were 36 consecutive ICC patients who had undergone hepatic resection between 1994 and 2005. The analyzed factors included various clinicopathological and surgical parameters, counts of microvessel stained for CD34 and expression of proliferative cell nuclear antigen.
RESULTS: The 1, 2, 3-year disease-free survival rates after surgery were 33, 18, and 0% and the 1, 3 and 5-year overall survival rates were 45, 29, and 8%. High CEA levels (> or = 10 ng/mL), excessive intraoperative blood loss (> or = 1000 mL) and presence of neighboring peritoneal dissemination were significantly associated with shorter disease-free survival (p < 0.05). High CEA levels, periductal invasion type, excessive intraoperative blood loss and non-fibrotic liver were significant factors associated with shorter overall survival (p < 0.05). Multivariate Cox proportional hazards regression model identified high CEA values, periductal invasive type, excessive intraoperative blood loss and non-fibrotic liver as significant and independent determinants of poor prognosis.
CONCLUSIONS: Hepatic resection with minimal blood loss followed by close follow-up is a suitable strategy for management of ICC patients with poor prognostic factors.

Entities:  

Mesh:

Year:  2007        PMID: 18265660

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study.

Authors:  Xianwu Luo; Lei Yuan; Yi Wang; Ruiliang Ge; Yanfu Sun; Gongtian Wei
Journal:  J Gastrointest Surg       Date:  2014-01-07       Impact factor: 3.452

2.  Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.

Authors:  Sun Mi Hong; Chang Wook Park; Hyung Jin Cha; Jung Hee Kwon; Young Sung Yun; Nam Gyu Lee; Dae-Ghon Kim; Hong Gil Nam; Kwan Yong Choi
Journal:  Clin Exp Metastasis       Date:  2012-08-09       Impact factor: 5.150

3.  Biliary tract intraductal papillary mucinous neoplasm: report of 19 cases.

Authors:  Xing Wang; Yun-Qiang Cai; Yong-Hua Chen; Xu-Bao Liu
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  Intraductal papillary mucinous neoplasm of the biliary tract: a real disease?

Authors:  Joshua G Barton; David A Barrett; Marco A Maricevich; Thomas Schnelldorfer; Christina M Wood; Thomas C Smyrk; Todd H Baron; Michael G Sarr; John H Donohue; Michael B Farnell; Michael L Kendrick; David M Nagorney; Kaye M Reid Lombardo; Florencia G Que
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

5.  Predictors of intraoperative blood loss in patients undergoing hepatectomy.

Authors:  Atsushi Nanashima; Takafumi Abo; Keiko Hamasaki; Kouki Wakata; Masaki Kunizaki; Kazuo Tou; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Tomoshi Tsuchiya; Takeshi Nagayasu
Journal:  Surg Today       Date:  2012-10-20       Impact factor: 2.549

6.  Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.

Authors:  Tomohide Nakayama; Takahiro Tsuchikawa; Toshiaki Shichinohe; Toru Nakamura; Yuma Ebihara; Satoshi Hirano
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.